Imee s half-truths on Self-Reliance Defense Posture verafiles.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from verafiles.org Daily Mail and Mail on Sunday newspapers.
60 Degrees Pharmaceuticals (SXTP) to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
60 Degrees Pharma (Nasdaq: SXTP) will sponsor a study using tafenoquine, an FDA-approved malaria drug, to treat canine babesiosis, a tick-borne disease..
To lead U.S. commercial relaunch of ARAKODA® for malaria preventionWill support Company plan to expand clinical research strategy in tick-borne diseases beyond acute babesiosis WASHINGTON,.
60 Degrees Pharmaceuticals (SXTP) Granted Additional U S Patent Covering Tafenoquine for Prevention of Plasmodium Falciparum Malaria streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.